Malta - English - Medicines Authority

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - lamivudine - film-coated tablet - lamivudine 300 mg - antivirals for systemic use

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - lamivudine 300 mg

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - lamivudine 150 mg

United States - English - NLM (National Library of Medicine)

kaiser foundation hospitals - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - lamivudine 100 mg

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - lamivudine tablet is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (hiv-l) infection.   limitation of use: the dosage of this product is for hiv-1and not for hbv. lamivudine tablets are contraindicated in patients with a previous hypersensitivity reaction to lamivudine. teratogenic effects pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to lamivudine during pregnancy. physicians are encouraged to register patients by calling the antiretroviral pregnancy registry at 1-800-258-4263.  risk summary available data from the antiretroviral pregnancy registry show no difference in the risk of overall major birth defects for lamivudine compared with the background rate for major birth defects of 2.7% in the us reference population of the metropolitan atlanta congenital d

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lamivudine 150mg; zidovudine 300mg - film coated tablet - active: lamivudine 150mg zidovudine 300mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white propylene glycol purified water sodium starch glycolate - indicated for the treatment of hiv infected adults and adolescents over the age of 12 years, with progressive immunodeficiency (cd4+ count = < 500 cells/mm³).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lamivudine 150mg;  ;   - film coated tablet - 150 mg - active: lamivudine 150mg     excipient: magnesium stearate microcrystalline cellulose opadry white propylene glycol purified water sodium starch glycolate - lamuvidine in combination with other anti-retroviral agents is indicated for the treatment of hiv-infected adults and children.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lamivudine 300mg - film coated tablet - 300 mg - active: lamivudine 300mg excipient: magnesium stearate microcrystalline cellulose opadry white propylene glycol purified water sodium starch glycolate - lamuvidine in combination with other anti-retroviral agents is indicated for the treatment of hiv-infected adults and children.

United States - English - NLM (National Library of Medicine)

kaiser foundation hospitals - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - lamivudine 100 mg

United States - English - NLM (National Library of Medicine)

unit dose services - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - lamivudine 150 mg